N 6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development.
Acta Pharm Sin B
; 8(6): 833-843, 2018 Oct.
Article
in En
| MEDLINE
| ID: mdl-30505654
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Acta Pharm Sin B
Year:
2018
Document type:
Article
Affiliation country:
China
Country of publication:
Netherlands